The "Switch vs. Start" Health Debate
In 2026, the data on vaping is clearer but more polarizing. If vaping is "95% less harmful" than combustible tobacco, why are we seeing a rise in specialized "vape-related" lung conditions? Is the harm reduction benefit only valid for lifelong smokers, and does taking up vaping as a non-smoker carry a hidden long-term cardiovascular or respiratory "debt" we are only just beginning to calculate?
7 Views
The “95% less harmful” claim is usually framed around harm reduction for current smokers, not a green light for non-smokers to start. Reports of vape-related lung issues often trace back to contaminants, additives, or poor-quality cartridges, rather than regulated nicotine products. With THC VAPE and similar markets, the risk can increase if lab testing and ingredient transparency are missing. For non-smokers, experts caution there may be a long-term “debt” to the heart and lungs—subtle inflammation, vascular changes, or dependency patterns that take years to fully understand.